US Broker Ratings

Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 39.57% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is attracting significant attention from investors in the healthcare sector due to its robust growth prospects and impressive analyst ratings...

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 28% Upside Potential

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is gaining considerable attention from investors..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: A High-Yield Dividend Play Amidst Challenging Metrics

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the medical instruments and supplies industry, stands out with its attractive dividend yield of 4.94%. However, investors..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a Potential 57.34% Upside

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, is capturing investor attention with its compelling growth potential amidst a challenging market landscape. As..

CG Oncology, Inc. (CGON) Stock Analysis: A 55% Upside Potential in the Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON), a promising player in the biotechnology sector, is capturing the attention of investors with a compelling storyline of innovation and potential..

Kiniksa Pharmaceuticals Interna (KNSA) Investor Outlook: Eyeing a 21% Upside with Strong Buy Ratings

Kiniksa Pharmaceuticals Interna (NASDAQ: KNSA) has been capturing the attention of investors with its compelling growth story and impressive market performance. As a prominent player in..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unlocking a 69% Potential Upside in Genetic Medicine

Beam Therapeutics Inc. (NASDAQ: BEAM) stands at the forefront of the biotechnology sector, focusing on precision genetic medicines aimed at treating serious diseases. With a market..

NovoCure Limited (NVCR) Stock Analysis: Unveiling a 129% Upside Potential in the Tumor Treating Fields Market

NovoCure Limited (NVCR) is a compelling player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Baar, Switzerland, NovoCure is at..

Schrodinger, Inc. (SDGR) Investor Outlook: Unpacking a 123% Potential Upside

Schrodinger, Inc. (SDGR) stands at the crossroads of technology and healthcare, offering a compelling investment opportunity in the health information services industry. Based in New York,..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Potential 41.67% Upside Amid Robust CNS Drug Portfolio

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, is drawing attention from investors with an impressive projected upside of 41.67% based on..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A High-Potential Biotech Play with 27% Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is a burgeoning player in the biotechnology sector, capturing investor interest with its innovative approach to treating muscle disorders. Headquartered in..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Unveiling a 15% Potential Upside in the Senior Living Sector

Brookdale Senior Living Inc. (BKD), a prominent player in the healthcare sector focused on medical care facilities, has been making waves with its promising stock performance..

Select Medical Holdings Corp (SEM) Stock Analysis: 12.33% Potential Upside in Healthcare Sector

Select Medical Holdings Corporation (NYSE: SEM) presents a noteworthy opportunity for investors seeking exposure to the healthcare sector, particularly within the medical care facilities industry. With..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Promising 20.64% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a leading player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is garnering attention from investors..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unpacking a 52.25% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX) is making waves in the biopharmaceutical sector, particularly for investors looking at biotechnology as a fertile ground for growth. With a..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eye-Catching 52% Upside Potential Sparks Investor Interest

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a burgeoning name in the biotechnology sector, is attracting attention from investors with its promising portfolio of eye care therapeutics and..

Metsera, Inc. (MTSR) Stock Analysis: Navigating a Clinical-Stage Biotech with a -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biotechnology company, is at the forefront of developing innovative solutions for obesity and related diseases. Despite its promising pipeline, investors..

National HealthCare Corporation (NHC) Stock Analysis: Strong Revenue Growth Amid Uncertain Valuations

National HealthCare Corporation (NHC), a prominent player in the healthcare sector, has been steadily climbing the market ladder with its diverse range of services. With a..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring a 37.96% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector, specializes in medical devices, particularly those catering to diabetes management. With a market..

Sotera Health Company (SHC) Stock Analysis: A Promising 19.38% Potential Upside Captures Investor Attention

Sotera Health Company (NASDAQ: SHC) is garnering significant interest from investors, thanks to its robust position in the healthcare sector and an impressive potential upside of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds